原发不明头颈癌失败模式与挽救治疗:DAHANCA全国研究
该研究基于丹麦DAHANCA数据库2014–2020年254例原发不明头颈鳞癌(HNSCCUP)患者,分析失败模式与挽救结局。43%为HPV相关(p16阳性)。dND组出现原发灶比例35%高于IMRT组6%,挽救治愈率分别为78%和27%。IMRT组区域失败多位于 elective CTV 内(89%)。
要点
- dND组原发灶出现率35%高于IMRT组6%,挽救治愈率78%对27%。
- IMRT组89%区域失败位于 elective CTV 内。
- 纳入挽救效应后dND与IMRT组局部区域失败无显著差异。
核心结论
- 研究结果支持基于HPV状态指导的个体化治疗策略,并强调治疗疗效分析应纳入挽救结局。
研究设计与样本
- 基于DAHANCA数据库的全国性连续队列,纳入2014–2020年254例HNSCCUP患者,进行基于影像的失败模式分析。
主要发现
- 254例中43%为HPV相关(p16阳性)。
- 治疗方式包括确定性颈清扫(dND,n=60)和含IMRT方案(n=194),为术后或原发IMRT伴或不伴辅助化疗。
- 71例(28%)在5年内出现失败。
- dND组原发灶出现率35%高于IMRT组6%,挽救治疗治愈率分别为78%和27%。
- IMRT组大多数区域失败位于 elective CTV 内(89%)。
临床怎么用
- 可依据HPV状态选择是否行黏膜照射的个体化策略。
- 评估治疗疗效时应纳入挽救治疗结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Failure patterns in patients with head and neck squamous cell carcinoma of unknown primary (HNSCCUP) depend on disease etiology and treatment type and extent. Treatment strategies may include radiotherapy to address any potential mucosal tumor sites, or alternatively, the omission of mucosal irradiation to permit targeted intervention should a primary tumor subsequently emerge. The Danish 2013 guidelines employed both strategies based on N-classification and Epstein-Barr Virus status, but not Human Papilloma Virus (HPV) status. The present study aimed to analyze failure patterns in a complete, nationwide Danish cohort of patients with HNSCCUP, with a focus on HPV status, treatment targets, and salvage outcomes. MATERIALS & METHODS: All HNSCCUP patients treated in the period 2014 to 2020, were identified in the DAHANCA database. An image-based pattern of failure analysis was conducted to evaluate the extent of primary treatment coverage at sites of recurrence. RESULTS: In a consecutive cohort of 254 HNSCCUP patients, 43 % had HPV-associated disease (p16 positivity). Treatment modalities included definitive neck dissection (dND) (n = 60) and treatment regiments involving intensity modulated radiotherapy (IMRT, n = 194); either postoperative or primary IMRT with or without adjuvant chemotherapy. 71 patients (28 %) experienced failure within 5 years. Anatomical localization of emerging primaries depended on HPV status and primary treatment modality. Higher rates of emerging primaries were seen in the dND group (35 %) compared to the IMRT group (6 %), with salvage treatment resulting in cure rates of 78 % and 27 %, respectively. Most regional failures in the IMRT group originated within elective clinical target volumes (89 %). No significant difference in loco-regional failure was observed when comparing the dND group with the IMRT group, when including salvage effects. CONCLUSION: The study findings support a personalized treatment strategy guided by HPV status and highlight the importance of including salvage outcomes in treatment efficacy analyses.
引用
- Nielsen SB, Kristensen MH, Holm AIS, et al. Failure pattern and salvage in head and neck cancer of unknown primary: A national study by DAHANCA. Radiother Oncol. 2025. PMID: 41016667. doi:10.1016/j.radonc.2025.111162
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。